TY - JOUR
T1 - Mechanisms of hepatic disposition of polystyrene microspheres in rats
T2 - Effects of serum depend on the sizes of microspheres
AU - Ogawara, Ken-ichi
AU - Yoshida, Minoru
AU - Kubo, Jun ichi
AU - Nishikawa, Makiya
AU - Takakura, Yoshinobu
AU - Hashida, Mitsuru
AU - Higaki, Kazutaka
AU - Kimura, Toshikiro
PY - 1999/9/20
Y1 - 1999/9/20
N2 - To study the mechanisms of the hepatic disposition of polystyrene microspheres (MS), effects of serum on their hepatic disposition characteristics were investigated for MSs with particle sizes of 50 nm (MS-50) and 500 nm (MS-500) by isolated liver perfusion experiments. It was revealed that serum in the perfusate inhibited and promoted the hepatic disposition of MS-50 and MS-500 at 37°C, respectively. However, pre-heating at 56°C or pre-treatment with anti-C3 antibody of serum reduced the promotive effect of serum on the hepatic uptake of MS-500, suggesting that the complement system should be involved as opsonins for the hepatic uptake of MS-500. Hepatic disposition of both MSs at 4°C was reduced by the addition of serum into the perfusate, which could be ascribed to the reduction of the surface hydrophobicity of MSs due to the adsorption of serum proteins onto the surface of MSs and to resultant decrease in non-specific disposition to the liver. From these results, serum was found to function both as the opsonin to enhance the hepatic uptake of MSs and as the inhibitor by reducing non-specific interaction between MSs and the plasma membrane. Whether serum promotes or inhibits the hepatic disposition of MSs would be dependent on the particle sizes of MSs. Copyright (C) 1999 Elsevier Science B.V.
AB - To study the mechanisms of the hepatic disposition of polystyrene microspheres (MS), effects of serum on their hepatic disposition characteristics were investigated for MSs with particle sizes of 50 nm (MS-50) and 500 nm (MS-500) by isolated liver perfusion experiments. It was revealed that serum in the perfusate inhibited and promoted the hepatic disposition of MS-50 and MS-500 at 37°C, respectively. However, pre-heating at 56°C or pre-treatment with anti-C3 antibody of serum reduced the promotive effect of serum on the hepatic uptake of MS-500, suggesting that the complement system should be involved as opsonins for the hepatic uptake of MS-500. Hepatic disposition of both MSs at 4°C was reduced by the addition of serum into the perfusate, which could be ascribed to the reduction of the surface hydrophobicity of MSs due to the adsorption of serum proteins onto the surface of MSs and to resultant decrease in non-specific disposition to the liver. From these results, serum was found to function both as the opsonin to enhance the hepatic uptake of MSs and as the inhibitor by reducing non-specific interaction between MSs and the plasma membrane. Whether serum promotes or inhibits the hepatic disposition of MSs would be dependent on the particle sizes of MSs. Copyright (C) 1999 Elsevier Science B.V.
KW - Dysopsonin
KW - Hepatic uptake
KW - Liver perfusion
KW - Opsonin
KW - Polystyrene microsphere
UR - http://www.scopus.com/inward/record.url?scp=0032883199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032883199&partnerID=8YFLogxK
U2 - 10.1016/S0168-3659(99)00121-2
DO - 10.1016/S0168-3659(99)00121-2
M3 - Article
C2 - 10477798
AN - SCOPUS:0032883199
SN - 0168-3659
VL - 61
SP - 241
EP - 250
JO - Journal of Controlled Release
JF - Journal of Controlled Release
IS - 3
ER -